Results 91 to 100 of about 27,055 (166)

スタートアップTDM

, 2019
openaire   +1 more source

Detection of Anti-Infliximab and Anti-Adalimumab Antibodies Below Manufacture's Threshold in a TDM Cohort Using Signal-to-Noise Ratio. [PDF]

Basic Clin Pharmacol Toxicol
Pedersen L.
europepmc   +1 more source

TDRPFormer: Texture-Debiased Reliable Prototype Transformer for Pixel-Level Steel Surface Defect Segmentation. [PDF]

Sensors (Basel)
Zhu M, Li Z, Sun H, Wang Y, Wang J.
europepmc   +1 more source

Voriconazole pseudotoxicity: a case report highlighting the importance of sampling timing in TDM interpretation by clinical pharmacists. [PDF]

Front Med (Lausanne)
Deng XM, Xu Y, Xie ZQ, Xu JJ, Mao KL, Sun HY.   +5 more
europepmc   +1 more source

Observed Trough-Based Vancomycin Dosing Decisions Versus Model-Predicted Bayesian AUC-Guided Recommendations. [PDF]

Healthcare (Basel)
Alghamdi WA.
europepmc   +1 more source

Population Pharmacokinetics of Subcutaneous Infliximab: A Real-World Study of Naïve and Switch Patients. [PDF]

Pharmaceutics
Vicente B, Zazo H, Sánchez-Hernández JG, Revilla N, Teixeira-da-Silva P.   +4 more
europepmc   +1 more source

How Feasible is the Use of Saliva for Antiviral Therapeutic Drug Monitoring? A Systematic Review and Analysis. [PDF]

Clin Pharmacokinet
Lai CW, Wenker SAM, Groundwater PW, Beardsley J, Sutrave G, Chen RH, Märtson AG, Alffenaar JC.   +7 more
europepmc   +1 more source

Bridging the Gap in Hydroxychloroquine Monitoring for Systemic Lupus Erythematosus: Evidence, Limitations, and Future Directions. [PDF]

Int J Rheum Dis
Lin CT, Cheng TK, Wei JC.
europepmc   +1 more source

TDMポケットガイド

, 1998
openaire   +1 more source